Prime Minister Justin Trudeau announced Friday that Pfizer-BioNTech has agreed to move up a portion of its vaccines scheduled for the summer, with an additional 1.5 million doses arriving in March.
This means Canada will have access to a total of eight million vaccine doses from Pfizer, Moderna, and AstraZeneca by the end of the first quarter, up from an original commitment of six million doses.
